Interesting reading . Thoughts and opinions welcom
Post# of 148190
(Total Views: 700)
Posted On: 08/05/2020 5:27:11 PM
Interesting reading . Thoughts and opinions welcome .
RLFTF... Published on July 16 2020. Interesting comparison... https://finance.yahoo.com/news/neurorx-relief...00368.html " Data Monitoring Committee determined that so far RLF-100 has generated no drug-related Serious Adverse Events or other safety concerns that would mandate stopping." "Primary endpoint is established as "Alive and free of Respiratory Failure"... At the committee’s recommendation, the primary endpoint is changed to "alive and free of respiratory failure at 7-10 days." "The committee determined that the study appeared capable of reaching a statistically significant endpoint within its 144 patient sample size and voted for the study to continue until its next scheduled evaluation in four weeks. " The following inclusion provided the identity of the DMSC members.. I never knew they were announced (?)..: "The committee is composed of Prof. Alfred Sommer, MD, MHS, Dean Emeritus of the Johns Hopkins Bloomberg School of Public Health, Prof. Rita Colwell, PhD, former Director of the National Science Foundation, and Congressman, Andy Harris, MD, MHS (MD District 1) a part time Professor of Anesthesia and Critical Care at Johns Hopkins School of Medicine."
RLFTF... Published on July 16 2020. Interesting comparison... https://finance.yahoo.com/news/neurorx-relief...00368.html " Data Monitoring Committee determined that so far RLF-100 has generated no drug-related Serious Adverse Events or other safety concerns that would mandate stopping." "Primary endpoint is established as "Alive and free of Respiratory Failure"... At the committee’s recommendation, the primary endpoint is changed to "alive and free of respiratory failure at 7-10 days." "The committee determined that the study appeared capable of reaching a statistically significant endpoint within its 144 patient sample size and voted for the study to continue until its next scheduled evaluation in four weeks. " The following inclusion provided the identity of the DMSC members.. I never knew they were announced (?)..: "The committee is composed of Prof. Alfred Sommer, MD, MHS, Dean Emeritus of the Johns Hopkins Bloomberg School of Public Health, Prof. Rita Colwell, PhD, former Director of the National Science Foundation, and Congressman, Andy Harris, MD, MHS (MD District 1) a part time Professor of Anesthesia and Critical Care at Johns Hopkins School of Medicine."
(1)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼